Nykode Stock Up As FDA Approves IND For VB-C-04 Trial Of VB10.16 In HPV16-Positive Cervical Cancer

(RTTNews) - Shares of Nykode Therapeutics ASA were gaining around 4 percent in the morning trading in Norway after the company announced that the ...

Related Keywords

Norway ,Oslo ,Norwegian ,Michael Engsig ,Roche Group ,Drug Administration ,Genentech ,Nykode Therapeutics ,New York ,